Blackrock Pharmaceuticals Limited is a rapidly expanding, privately owned company focused on the development and marketing of high quality, specialist generic medicines, and consumer healthcare products, across the UK and Europe.
Our aim is to explore, understand and meet real unmet patient needs.
With regulatory expertise at our core, we are a trusted partner for manufacturers to expand their product revenues in new geographies.
Product launch: Hydroxychloroquine Sulfate 300 mg film-coated tablets now available. View Press Release